The people behind Soraya

Mark Sean Taylor

"In a bid to reduce the inevitable following an early-stage pancreatic cancer diagnosis, I decided to concentrate my life mission on helping patients establish effective solutions for cancer."

The initiative is led by Mark Sean Taylor, who holds an MSc in Financial Engineering and an MBA, and spent 20 years working in finance and technology across London, New York, Hong Kong, Istanbul and Sao Paulo. In 2016 he was diagnosed with minimal residual disease pancreatic cancer through circulating tumour cells.

He was rejected for standard-of-care medicine, as the level of cancer was below what mainstream medicine recognises for a formal diagnosis. This forced him into integrative medicine as an initial skeptic. He has since spent over $500,000 USD on treatments and tests at some of the top medical institutions around the world, learning the approaches of some of the world's leading integrative doctors.

After starting the Patient Led Oncology Trials Facebook group, tracking the progress of hundreds of cancer patients following almost every well-known integrative treatment, he has identified effective approaches that work well, supported by data, patient reports and research. He is an avid cancer researcher who now works with and advises some of the top integrative cancer clinics around the world.

Dr. Eleanor Liney

"Rigorous scientific review ensures that patients navigating complex oncology data can trust every study citation and rely on uncompromised evidence."

Dr. Eleanor Liney brings exceptional scientific rigor and personal resilience to the platform. Holding a degree and a PhD in Physical Chemistry from Cambridge University, she combines deep molecular expertise with the lived perspective of a 5-year cancer survivor.

Having navigated her own cancer journey, Eleanor dedicated herself to patient advocacy and scientific evaluation. She has conducted exhaustive reviews of the foundational research and studies underpinning the Hacking Cancer curriculum and personalized reports, examining literature with meticulous academic precision.

Her commitment ensures that claims, study citations, and references in the platform's literature database meet the highest standards of scientific accuracy, bridging advanced physical chemistry research with trustworthy guidance for patients and caregivers.

Gabriele Gavazzi

"Within the next 5 to 10 years, cancer will become as manageable as diabetes is today."

Gabriele brings a unique background holding an MSc in Financial Engineering, combined with entrepreneurial biology, combined with a profound personal history of cancer affecting family members. When his 85-year-old grandmother faced a stage 2 colorectal cancer metastasis with a stark prognosis, he embarked on an intensive research journey across over 3,000 studies.

Focusing on off-label use, immunotherapy, and metabolic pathways, Gabriele developed three investigative research frameworks that helped extend her quality of life significantly. Meeting Mark and joining Patient Led Oncology Trials inspired him to bridge the gap between complex medical literature and everyday patient needs, leading him to author a book that demystifies cancer research.